SCHEMBL6405069

SCHEMBL6405069

Cc1c(CC(N)=O)cccc1Sc1ccccc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 1/20 0.43
GAA P10253 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
AKR1B1 P15121 1/20 0.40
HPGD P15428 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PLA2G2A P14555 1/20 0.38
MAPT P10636 3/20 0.37
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
G6PD P11413 1/20 0.37
PKM P14618 1/20 0.37
RECQL P46063 1/20 0.37
CCR6 P51684 1/20 0.37
MCL1 Q07820 1/20 0.37
HKDC1 Q2TB90 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5210376 0.82 GAA (0.50) GAANPSR1AKR1B1HPGDPLA2G2A
SCHEMBL6412426 0.76 KDM4E (0.53) P4HBGAAHPGDLMNASMN1; SMN2
SCHEMBL1569021 0.75 LMNA (0.47) GAANPSR1HPGDCYP2C9CYP2C19
SCHEMBL28787217 0.75 APOBEC3G (0.54) GAANPSR1AKR1B1HPGDCYP2C9
SCHEMBL299227 0.74 AKR1B1 (0.68) GAANPSR1AKR1B1HPGDMAPT
SCHEMBL4655209 0.74 AKR1B1 (0.68) GAANPSR1AKR1B1HPGDMAPT
SCHEMBL12090255 0.73 P4HB (0.57) P4HBGAAAKR1B1HPGDCYP2C9
SCHEMBL339508 0.73 P2RX7 (0.44) GAANPSR1MAPTMAPK1ALDH1A1
Methane SCHEMBL22289679 0.73 AKR1B1 (0.65) GAANPSR1AKR1B1HPGDMAPT
SCHEMBL4100411 0.72 CYP3A4 (0.48) GAANPSR1HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050196819-A1 Methods and compositions to lower plasma cholesterol levels ATHEROGENICS PHARMACEUTICALS, INC. 2005-09-08 US disclosed
US-6887712-B1 Methods and compositions to lower plasma cholesterol levels ATHEROGENICS, INC. (US) 2005-05-03 US disclosed